Dyne Therapeutics DYN
NASDAQ DYN
$17.99 +0.07 (+0.39%)
As of: Nov 11, 2026 · 3:59 PM EST

Dyne Therapeutics (DYN) Other financing activities (as filed) (2025 - 2026)

Updated

Dyne Therapeutics' Other financing activities was $30,000 in Q1 2026, up 233.3% from the prior quarter.

Analysis

Dyne Therapeutics (DYN) Other financing activities (as filed) (2025 - 2026) Analysis & Trends

For FY2025, Other financing activities at Dyne Therapeutics came in at $558,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Dyne Therapeutics 3.36 Bn -757.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -56,000.00
Mar 31, 2026 -30,000.00
Dec 31, 2025 -9,000.00
Sep 30, 2025 -549,000.00
API Access

Dyne Therapeutics Other financing activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=DYN&period=max&api_key=YOUR_API_KEY